Cargando…

Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives

The efforts made to develop RNAi-based therapies have led to productive research in the field of infections in humans, such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), human cytomegalovirus (HCMV), herpetic keratitis, human papillomavirus, or influenza vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torrecilla, Josune, Rodríguez-Gascón, Alicia, Solinís, María Ángeles, del Pozo-Rodríguez, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145386/ https://www.ncbi.nlm.nih.gov/pubmed/25184135 http://dx.doi.org/10.1155/2014/161794

Ejemplares similares

MMP-9 Downregulation with Lipid Nanoparticles for Inhibiting Corneal Neovascularization by Gene Silencing
por: Torrecilla, Josune, et al.
Publicado: (2019)

Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2014)

Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA
por: Gómez-Aguado, Itziar, et al.
Publicado: (2020)

Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease
por: Beraza-Millor, Marina, et al.
Publicado: (2023)

Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease
por: Rodríguez-Castejón, Julen, et al.
Publicado: (2022)

Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy
por: Ruiz de Garibay, Aritz Pérez, et al.
Publicado: (2012)

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
por: Gómez-Aguado, Itziar, et al.
Publicado: (2020)

α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice
por: Rodríguez-Castejón, Julen, et al.
Publicado: (2021)

The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2023)

Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production
por: Vicente-Pascual, Mónica, et al.
Publicado: (2020)

mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation
por: Gómez-Aguado, Itziar, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2021)

Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine
por: Ibar-Bariain, Maitane, et al.
Publicado: (2019)

Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections
por: Hajiaghapour Asr, Mena, et al.
Publicado: (2023)

RNAi-based therapeutics–current status, challenges and prospects
por: Tiemann, Katrin, et al.
Publicado: (2009)

Lipid nanoceuticals: Current status and future perspective
por: Narang, Jasjeet Kaur
Publicado: (2014)

Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis
por: Valero, Ana, et al.
Publicado: (2021)

Lipid Nanoparticles as Carriers for Bioactive Delivery
por: Dhiman, Neerupma, et al.
Publicado: (2021)

Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer
por: Jung, Hun Soon, et al.
Publicado: (2015)

Defense Mechanisms against Viral Infection in Drosophila: RNAi and Non-RNAi
por: Swevers, Luc, et al.
Publicado: (2018)

Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia
por: Hu, Bo, et al.
Publicado: (2022)

Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
por: Costa, Cláudia Pina, et al.
Publicado: (2021)

Bacteria in Nanoparticle Synthesis: Current Status and Future Prospects
por: Iravani, Siavash
Publicado: (2014)

RNAi in the regulation of mammalian viral infections
por: Jeang, Kuan-Teh
Publicado: (2012)

Current and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform
por: Satterlee, Andrew B., et al.
Publicado: (2016)

Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies
por: Alarcia-Lacalle, Ana, et al.
Publicado: (2021)

RNAi for Treating Hepatitis B Viral Infection
por: Chen, Yong, et al.
Publicado: (2007)

Solid Lipid Nanoparticles as Carriers of Natural Phenolic Compounds
por: Borges, Alexandra, et al.
Publicado: (2020)

Endoscopic Bariatric Therapies: Current Status and Future Perspectives
por: Ibrahim Mohamed, Baraa Kamal, et al.
Publicado: (2022)

A novel therapeutic strategy for cartilage diseases based on lipid nanoparticle-RNAi delivery system
por: Wang, Shaowei, et al.
Publicado: (2018)

Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
por: Bilbao-Meseguer, Idoia, et al.
Publicado: (2022)

A status report on RNAi therapeutics
por: Vaishnaw, Akshay K, et al.
Publicado: (2010)

Solid Lipid Nanoparticles of Guggul Lipid as Drug Carrier for Transdermal Drug Delivery
por: Gaur, Praveen Kumar, et al.
Publicado: (2013)

Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
por: Viegas, Cláudia, et al.
Publicado: (2023)

Large Area Patterning of Nanoparticles and Nanostructures: Current Status and Future Prospects
por: Barad, Hannah-Noa, et al.
Publicado: (2021)

In vitro and in vivo correlation for lipid-based formulations: Current status and future perspectives
por: Huang, Yanping, et al.
Publicado: (2021)

Topical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal Neovascularization
por: Taketani, Yukako, et al.
Publicado: (2016)

RNA Viruses and RNAi: Quasispecies Implications for Viral Escape
por: Presloid, John B., et al.
Publicado: (2015)

Viral Vectors Applied for RNAi-Based Antiviral Therapy
por: Lundstrom, Kenneth
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h80jmhrchsph5gjv2afodt643d